Sustained molecular remission after arsenic trioxide and gemutuzumab ozogamicin in a pediatric patient with relapsed acute promyelocytic leukemia.
Akiko Inoue, Chihiro Kawakami, Kimitaka Takitani, Hiroshi Tamai
Index: Pediatr. Hematol. Oncol. 29(2) , 170-2, (2012)
Full Text: HTML
Abstract
Related Compounds
Related Articles:
2014-08-01
[Hum. Immunol. 75(8) , 923-9, (2014)]
2014-10-01
[Neurobiol. Learn. Mem. 114 , 127-40, (2014)]
2013-10-01
[Cancer Sci. 104(10) , 1339-45, (2013)]
2016-03-01
[Methods 96 , 46-58, (2016)]
2015-01-01
[PLoS ONE 10 , e0140262, (2015)]